SHOCKWAVE MED INC's ticker is SWAV and the CUSIP is 82489T104. A total of 236 filers reported holding SHOCKWAVE MED INC in Q2 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $709,873 | +74.3% | 2,180 | +2.0% | 0.01% | +66.7% |
| Q4 2023 | $407,227 | -8.5% | 2,137 | -4.4% | 0.00% | 0.0% |
| Q3 2023 | $444,989 | -30.3% | 2,235 | -0.1% | 0.00% | -40.0% |
| Q2 2023 | $638,748 | +280052.6% | 2,238 | +112.5% | 0.01% | +150.0% |
| Q1 2023 | $228 | -32.5% | 1,053 | -36.0% | 0.00% | -33.3% |
| Q4 2022 | $338 | -99.9% | 1,645 | -2.3% | 0.00% | -25.0% |
| Q3 2022 | $483,000 | +219.9% | 1,683 | +113.0% | 0.00% | +300.0% |
| Q2 2022 | $151,000 | -29.8% | 790 | -23.9% | 0.00% | -50.0% |
| Q1 2022 | $215,000 | +49.3% | 1,038 | +4.8% | 0.00% | +100.0% |
| Q4 2021 | $144,000 | -33.3% | 990 | -5.7% | 0.00% | 0.0% |
| Q3 2021 | $216,000 | +8.5% | 1,050 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $199,000 | +45.3% | 1,050 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $137,000 | +55.7% | 1,050 | +23.5% | 0.00% | 0.0% |
| Q4 2020 | $88,000 | +37.5% | 850 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $64,000 | – | 850 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prossimo Advisors, LLC | 18,758 | $3,857 | 8.92% |
| Atika Capital Management LLC | 122,593 | $25,206,347 | 3.62% |
| GILDER GAGNON HOWE & CO LLC | 705,880 | $145,135,955 | 2.71% |
| Alcosta Capital Management, Inc. | 10,470 | $2,152,737 | 2.17% |
| AtonRa Partners | 7,535 | $1,549,271 | 1.97% |
| Matisse Capital | 20,142 | $2,072,769 | 1.84% |
| SECTORAL ASSET MANAGEMENT INC | 39,100 | $8,039,351 | 1.56% |
| Nicholas Investment Partners, LP | 84,507 | $17,375,484 | 1.52% |
| Biondo Investment Advisors, LLC | 31,238 | $6,422,845 | 1.43% |
| Seaport Global Advisors, LLC | 1,616 | $332,266 | 1.15% |